A Simple Strategy to Reduce Contrast Media Use and Risk of Contrast-Induced Renal Injury during PCI: Introduction of an “Optimal Contrast Volume Protocol” to Daily Clinical Practice

Contrast-induced acute kidney injury is the leading cause of iatrogenic acute nephropathy. Development of contrast-induced nephropathy (CIN) increases the risk of adverse long- and short-term patients outcomes, the hospital costs, and length of hospitalization. There are a couple of methods described for CIN prevention (statin prescription, prehydration, contrast media (CM) clearance from the blood system, and decrease amounts of contrast volume). The CM volume to patient’s creatinine clearance ratio is the main factor to predict the risk of CIN development. The safe CM to creatinine clearance ratio limits have been established. The usage of CM amount depends on personal operators habits and inside center regulations. There is no standardized contrast usage protocol worldwide. The aim of this study was to establish an easy to use, cheap, and efficient protocol to estimate a personalized safe CM dose limit for every patient based on their kidney function. These limits are announced during the “Time Out” before the procedure. Our study included 519 patients undergoing interventional coronary procedures: 207 patients into the “Optimal Contrast Volume” arm and 312 into the control group. Applying the protocol into a daily clinical practice leads to a significant reduction in CM volume used for all type of procedures and the development of CIN in comparison with a control group.

[1]  S. Campo,et al.  Acute Kidney Injury and Sepsis after Cardiac Surgery: The Roles of Tissue Inhibitor Metalloproteinase-2, Insulin-like Growth Factor Binding Protein-7, and Mid-Regional Pro-Adrenomedullin , 2023, Journal of clinical medicine.

[2]  Edward G. Clark,et al.  Canadian Association of Radiologists Guidance on Contrast Associated Acute Kidney Injury , 2022, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[3]  N. Irrera,et al.  Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease , 2022, Journal of clinical medicine.

[4]  F. Wilson,et al.  AACC Guidance Document on Laboratory Investigation of Acute Kidney Injury. , 2021, The journal of applied laboratory medicine.

[5]  J. Gore,et al.  ACR Appropriateness Criteria® Renal Failure. , 2021, Journal of the American College of Radiology : JACR.

[6]  A. Colombo,et al.  Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Kidney Disease. , 2019, The Journal of invasive cardiology.

[7]  H. Gurm,et al.  Contemporary use of and outcomes associated with ultra‐low contrast volume in patients undergoing percutaneous coronary interventions , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[8]  A. Colombo,et al.  Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media. , 2018, International journal of cardiology.

[9]  S. Fakhran,et al.  Contrast-Induced Acute Kidney Injury: Pathophysiology, Manifestations, Prevention, and Management. , 2017, Magnetic resonance imaging clinics of North America.

[10]  A. Kastrati,et al.  Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence From a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients , 2017, Circulation. Cardiovascular interventions.

[11]  Mingyu Liang,et al.  Antithrombin III Protects Against Contrast-Induced Nephropathy , 2017, EBioMedicine.

[12]  N. Kafkas,et al.  Neutrophil Gelatinase–Associated Lipocalin as an Early Marker of Contrast‐Induced Nephropathy After Elective Invasive Cardiac Procedures , 2016, Clinical cardiology.

[13]  H. Ly,et al.  Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies. , 2016, The Canadian journal of cardiology.

[14]  B. Eryonucu,et al.  Is Kidney Injury Molecule 1 a Valuable Tool for the Early Diagnosis of Contrast-Induced Nephropathy? , 2015, Journal of Investigative Medicine.

[15]  S. David,et al.  Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study , 2015, Renal failure.

[16]  Y. Ikari,et al.  Safety margin of minimized contrast volume during percutaneous coronary intervention in patients with chronic kidney disease , 2014, Cardiovascular Intervention and Therapeutics.

[17]  A. Khwaja KDIGO Clinical Practice Guidelines for Acute Kidney Injury , 2012, Nephron Clinical Practice.

[18]  H. Gurm,et al.  Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. , 2011, Journal of the American College of Cardiology.

[19]  Richard Solomon,et al.  Contrast-induced acute kidney injury. , 2010, Circulation.

[20]  G. Sangiorgi,et al.  Mehran Contrast-Induced Nephropathy Risk Score Predicts Short- and Long-Term Clinical Outcomes in Patients With ST-Elevation–Myocardial Infarction , 2010, Circulation. Cardiovascular interventions.

[21]  Jeremiah R. Brown,et al.  Does Safe Dosing of Iodinated Contrast Prevent Contrast-Induced Acute Kidney Injury? , 2010, Circulation. Cardiovascular interventions.

[22]  K. Eagle,et al.  Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction. , 2009, European heart journal.

[23]  F. Veglia,et al.  Contrast Volume During Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality , 2009, Annals of Internal Medicine.

[24]  Jeremiah R. Brown,et al.  Serious renal dysfunction after percutaneous coronary interventions can be predicted. , 2008, American heart journal.

[25]  W. Laskey,et al.  Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. , 2007, Journal of the American College of Cardiology.

[26]  John A Kellum,et al.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury , 2007, Critical care.

[27]  Charles Davidson,et al.  Risk prediction of contrast-induced nephropathy. , 2006, The American journal of cardiology.

[28]  Joseph V Bonventre,et al.  Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. , 2005, Journal of the American Society of Nephrology : JASN.

[29]  G. Stone,et al.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.

[30]  B. McNeil,et al.  "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. , 2004, Journal of the American Society of Nephrology : JASN.

[31]  K. Harjai,et al.  Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. , 2004, The American journal of cardiology.

[32]  R. Bersin,et al.  Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.

[33]  A. Takeshita,et al.  The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study , 2003 .

[34]  K. Kent,et al.  Percutaneous coronary intervention‐associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[35]  Rosario V. Freeman,et al.  Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. , 2002, The American journal of cardiology.

[36]  Kirk N. Garratt,et al.  Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention , 2002, Circulation.

[37]  G. Stone,et al.  Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. , 2002, The Journal of invasive cardiology.

[38]  S. Marsch,et al.  Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. , 2002, Archives of internal medicine.

[39]  G. Dangas,et al.  Acute renal failure requiring dialysis after percutaneous coronary interventions , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[40]  G. Dangas,et al.  The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. , 2000, Journal of the American College of Cardiology.

[41]  W. O’Neill,et al.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.

[42]  L. Hillis,et al.  Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. , 1989, The American journal of medicine.

[43]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[44]  Michael E Matheny,et al.  Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. , 2014, JACC. Cardiovascular interventions.

[45]  A. Jeremias,et al.  Impact of Severity of Renal Dysfunction on Determinants of In-Hospital Mortality Among Patients Undergoing Percutaneous Coronary Intervention , 2012 .

[46]  A. Budaj,et al.  Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events). , 2009, JACC. Cardiovascular interventions.

[47]  E. Halpern,et al.  Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. , 1995, Kidney international.